SETH LOFGREEN: Open Payments
NPI 1801259023 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 55 payments from 17 companies in 2025. Trend: 2023 $1,193 · 2024 $953 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $173 |
| LEO Pharma Inc. | 5 | $129 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| Novartis Pharmaceuticals Corporation | 4 | $124 |
| UCB, Inc. | 4 | $103 |
| Galderma Laboratories, L.P. | 5 | $99 |
| Organogenesis Inc. | 3 | $96 |
| GENZYME CORPORATION | 3 | $90 |
| PFIZER INC. | 4 | $83 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $83 |
Products named: DUPIXENT, ADBRY, RINVOQ, Bimzelx, NEMLUVIO, COSENTYX, TREMFYA, SKYRIZI.
Industry payments across CO — which companies pay providers there.
